The effects of diet-induced obesity on B cell function

Clinical and Experimental Immunology

Volumn 179, Issue 1, 2015, Pages 90-99

  Shaikh, S R ^a   Haas, K M ^b   Beck, M A ^c   Teague, H ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c University of North Carolina   (United States)

Author keywords

B cell; Diabetes; Inflammation; Lipid mediators

Indexed keywords

AUTOANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN A; INTERLEUKIN 10; INTERLEUKIN 8; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; TUMOR NECROSIS FACTOR ALPHA; MEMBRANE ANTIGEN; UNSATURATED FATTY ACID;

ANTIBODY PRODUCTION; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC INFLAMMATION; COMORBIDITY; CYTOKINE RELEASE; DIET INDUCED OBESITY; FAT INTAKE; HEMATOPOIETIC STEM CELL; HUMAN; HUMORAL IMMUNITY; INNATE IMMUNITY; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIPID DIET; LYMPHOCYTE FUNCTION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOGENESIS; PHENOTYPE; PLASMABLAST; PRE B LYMPHOCYTE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH17 CELL; UPREGULATION; ADIPOSE TISSUE; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; DIET; IMMUNOLOGY; INFLAMMATION; METABOLISM; PATHOLOGY; T LYMPHOCYTE SUBPOPULATION;

ADIPOSE TISSUE; ANIMALS; ANTIGENS, SURFACE; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; CELL DIFFERENTIATION; COMORBIDITY; DIET; FATTY ACIDS, UNSATURATED; HUMANS; IMMUNITY, HUMORAL; INFLAMMATION; OBESITY; PHENOTYPE; T-LYMPHOCYTE SUBSETS;

EID: 84925294487     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12444     Document Type: Review

References (107)

1. Mauri C, Bosma A. Immune regulatory function of B cells. Ann Rev Immunol 2012; 30:221-241.
2. Candando KM, Lykken JM, Tedder TF. B10 cell regulation of health and disease. Immunol Rev 2014; 259:259-272.
3. Nagasawa T. Microenvironmental niches in the bone marrow required for B-cell development. Nat Rev Immunol 2006; 6:107-116.
4. Allman D, Li J, Hardy RR. Commitment to the B lymphoid lineage occurs before DH-JH recombination. J Exp Med 1999; 189:735-740.
5. Herzog S, Reth M, Jumaa H. Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling. Nat Rev Immunol 2009; 9:195-205.
6. King LB, Monroe JG. Immunobiology of the immature B cell: plasticity in the B-cell antigen receptor-induced response fine tunes negative selection. Immunol Rev 2000; 176:86-104.
7. Pillai S, Cariappa A. The follicular versus marginal zone B lymphocyte cell fate decision. Nat Rev Immunol 2009; 9:767-777.
8. Pillai S, Cariappa A, Moran ST. Marginal zone B cells. Annu Rev Immunol 2005; 23:161-196.
9. Baumgarth N. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat Rev Immunol 2011; 11:34-46.
10. Shen P, Roch T, Lampropoulou V etal. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature 2014; 507:366-370.
11. Mizoguchi A, Mizoguchi E, Takedatsu H, Blumberg RS, Bhan AK. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 2002; 16:219-230.
12. Zuccarino-Catania GV, Sadanand S, Weisel FJ etal. CD80 and PD-L2 define functionally distinct memory B cell subsets that are independent of antibody isotype. Nat Immunol 2014; 15:631-637.
13. Weber GF, Chousterman BG, Hilgendorf I etal. Pleural innate response activator B cells protect against pneumonia via a GM-CSF-IgM axis. J Exp Med 2014; 211:1243-1256.
14. Rauch PJ, Chudnovskiy A, Robbins CS etal. Innate response activator B cells protect against microbial sepsis. Science 2012; 335:597-601.
15. Shapiro-Shelef M, Calame K. Regulation of plasma-cell development. Nat Rev Immunol 2005; 5:230-242.
16. Shlomchik MJ, Weisel F. Germinal center selection and the development of memory B and plasma cells. Immunol Rev 2012; 247:52-63.
17. Zuidscherwoude M, de Winde CM, Cambi A, van Spriel AB. Microdomains in the membrane landscape shape antigen-presenting cell function. J Leukoc Biol 2014; 95:251-263.
18. Clark MR, Mandal M, Ochiai K, Singh H. Orchestrating B cell lymphopoiesis through interplay of IL-7 receptor and pre-B cell receptor signalling. Nat Rev Immunol 2014; 14:69-80.
19. Clark MR, Cooper AB, Wang LD, Aifantis I. The pre-B cell receptor in B cell development: recent advances, persistent questions and conserved mechanisms. Curr Top Microbiol Immunol 2005; 290:87-103.
20. Nemazee D. Receptor editing in lymphocyte development and central tolerance. Nat Rev Immunol 2006; 6:728-740.
21. Allman D, Lindsley RC, DeMuth W, Rudd K, Shinton SA, Hardy RR. Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J Immunol 2001; 167:6834-6840.
22. Treml LS, Carlesso G, Hoek KL etal. TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells. J Immunol 2007; 178:7531-7539.
23. He B, Santamaria R, Xu W etal. The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88. Nat Immunol 2010; 11:836-845.
24. Janeway CA Jr, Medzhitov R. Innate immune recognition. Ann Rev Immunol 2002; 20:197-216.
25. Cerutti A, Cols M, Puga I. Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes. Nat Rev Immunol 2013; 13:118-132.
26. Cinamon G, Zachariah MA, Lam OM, Foss FW, Cyster JG. Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat Immunol 2008; 9:54-62.
27. Hao Z, Rajewsky K. Homeostasis of peripheral B cells in the absence of B cell influx from the bone marrow. J Exp Med 2001; 194:1151-1164.
28. Martin F, Oliver AM, Kearney JF. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 2001; 14:617-629.
29. Bos NA, Kimura H, Meeuwsen CG etal. Serum immunoglobulin levels and naturally occurring antibodies against carbohydrate antigens in germ-free BALB/c mice fed chemically defined ultrafiltered diet. Eur J Immunol 1989; 19:2335-2339.
30. Haury M, Sundblad A, Grandien A, Barreau C, Coutinho A, Nobrega A. The repertoire of serum IgM in normal mice is largely independent of external antigenic contact. Eur J Immunol 1997; 27:1557-1563.
31. Hooijkaas H, Benner R, Pleasants JR, Wostmann BS. Isotypes and specificities of immunoglobulins produced by germ-free mice fed chemically defined ultrafiltered 'antigen-free' diet. Eur J Immunol 1984; 14:1127-1130.
32. Baumgarth N, Herman OC, Jager GC, Brown LE, Herzenberg LA, Chen J. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J Exp Med 2000; 192:271-280.
33. Boes M, Prodeus AP, Schmidt T, Carroll MC, Chen J. A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med 1998; 188:2381-2386.
34. Ochsenbein AF, Fehr T, Lutz C etal. Control of early viral and bacterial distribution and disease by natural antibodies. Science 1999; 286:2156-2159.
35. Zhou ZH, Zhang Y, Hu YF, Wahl LM, Cisar JO, Notkins AL. The broad antibacterial activity of the natural antibody repertoire is due to polyreactive antibodies. Cell Host Microbe 2007; 1:51-61.
36. Kaminski DA, Stavnezer J. Enhanced IgA class switching in marginal zone and B1 B cells relative to follicular/B2 B cells. J Immunol 2006; 177:6025-6029.
37. Tarlinton DM, McLean M, Nossal GJ. B1 and B2 cells differ in their potential to switch immunoglobulin isotype. Eur J Immunol 1995; 25:3388-3393.
38. Roy B, Brennecke AM, Agarwal S, Krey M, Duber S, Weiss S. An intrinsic propensity of murine peritoneal B1b cells to switch to IgA in presence of TGF-beta and retinoic acid. PLOS ONE 2013; 8:e82121.
39. Yanaba K, Bouaziz JD, Haas KM, Poe JC, Fujimoto M, Tedder TF. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 2008; 28:639-650.
40. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM. B cells regulate autoimmunity by provision of IL-10. Nat Immunol 2002; 3:944-950.
41. Carter NA, Vasconcellos R, Rosser EC etal. Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J Immunol 2011; 186:5569-5579.
42. Finkelstein EA, Trogdon JG, Cohen JW, Dietz W. Annual medical spending attributable to obesity: payer- and service-specific estimates. Health Aff 2009; 28:w822-w831.
43. Prospective studies C. Body-mass index and cause-specific mortality in 900000 adults: collaborative analyses of 57 prospective studies. Lancet 2009; 373:1083-1096.
44. Malik VS, Willett WC, Hu FB. Global obesity: trends, risk factors and policy implications. Nat Rev Endocrinol 2013; 9:13-27.
45. Manson JE, Colditz GA, Stampfer MJ etal. A prospective study of obesity and risk of coronary heart disease in women. N Eng J Med 1990; 322:882-889.
46. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348:1625-1638.
47. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007; 117:175-184.
48. Nishimura S, Manabe I, Nagasaki M etal. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 2009; 15:914-920.
49. Winer S, Chan Y, Paltser G etal. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 2009; 15:921-929.
50. Feuerer M, Herrero L, Cipolletta D etal. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 2009; 15:930-939.
51. Winer S, Paltser G, Chan Y etal. Obesity predisposes to Th17 bias. Eur J Immunol 2009; 39:2629-2635.
52. Chen Y, Tian J, Tian X etal. Adipose tissue dendritic cells enhances inflammation by prompting the generation of Th17 cells. PLOS ONE 2014; 9:e92450.
53. Zhong J, Rao X, Braunstein Z etal. T-cell costimulation protects obesity-induced adipose inflammation and insulin resistance. Diabetes 2014; 63:1289-1302.
54. Bertola A, Ciucci T, Rousseau D etal. Identification of adipose tissue dendritic cells correlated with obesity-associated insulin-resistance and inducing Th17 responses in mice and patients. Diabetes 2012; 61:2238-2247.
55. Schipper HS, Rakhshandehroo M, van de Graaf SFJ etal. Natural killer T cells in adipose tissue prevent insulin resistance. J Clin Invest 2012; 122:3343-3354.
56. Lynch L, Nowak M, Varghese B etal. Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production. Immunity 2012; 37:574-587.
57. Wu D, Molofsky AB, Liang H-E etal. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 2011; 332:243-247.
58. Adler BJ, Green DE, Pagnotti GM, Chan ME, Rubin CT. High fat diet rapidly suppresses B lymphopoiesis by disrupting the supportive capacity of the bone marrow niche. PLOS ONE 2014; 9:e90639.
59. Trottier MD, Naaz A, Li Y, Fraker PJ. Enhancement of hematopoiesis and lymphopoiesis in diet-induced obese mice. Proc Natl Acad Sci USA 2012; 109:7622-7629.
60. Winer D, Winer S, Shen L etal. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med 2011; 17:610-617.
61. Ballak DB, Stienstra R, Hijmans A, Joosten LAB, Netea MG, Tack CJ. Combined B- and T-cell deficiency does not protect against obesity-induced glucose intolerance and inflammation. Cytokine 2013; 62:96-103.
62. Deng T, Lyon Christopher J, Minze Laurie J etal. Class II major histocompatibility complex plays an essential role in obesity-induced adipose inflammation. Cell Metab 2013; 17:411-422.
63. DeFuria J, Belkina AC, Jagannathan-Bogdan M etal. B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. Proc Natl Acad Sci USA 2013; 110:5133-5138.
64. Zhu M, Belkina AC, DeFuria J etal. B cells promote obesity-associated periodontitis and oral pathogen-associated inflammation. J Leukoc Biol 2014; 96:349-357.
65. Jagannathan M, McDonnell M, Liang Y etal. Toll-like receptors regulate B cell cytokine production in patients with diabetes. Diabetologia 2010; 53:1461-1471.
66. van Exel E, Gussekloo J, de Craen AJM, Frölich M, Bootsma-van der Wiel A, Westendorp RGJ. Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes: the leiden 85-plus study. Diabetes 2002; 51:1088-1092.
67. Kim H-J, Higashimori T, Park S-Y etal. Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo. Diabetes 2004; 53:1060-1067.
68. Nishimura S, Manabe I, Takaki S etal. Adipose natural regulatory B cells negatively control adipose tissue inflammation. Cell Metab 2013; 18:759-766.
69. Wang R-X, Yu C-R, Dambuza IM etal. Interleukin-35 induces regulatory B cells that suppress autoimmune disease. Nat Med 2014; 20:633-641.
70. Huang S, Rutkowsky JM, Snodgrass RG etal. Saturated fatty acids activate TLR-mediated proinflammatory signaling pathways. J Lipid Res 2012; 53:2002-2013.
71. Rockett BD, Salameh M, Carraway K, Morrison K, Shaikh SR. n-3 PUFA improves fatty acid composition, prevents palmitate-induced apoptosis, and differentially modifies B cell cytokine secretion in vitro and ex vivo. J Lipid Res 2010; 51:1284-1297.
72. Wong SW, Kwon M-J, Choi AMK, Kim H-P, Nakahira K, Hwang DH. Fatty acids modulate Toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner. J Biol Chem 2009; 284:27384-27392.
73. Schaffer JE. Lipotoxicity: when tissues overeat. Curr Opin Lipidol 2003; 14:281-287.
74. Listenberger LL, Han X, Lewis SE etal. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci USA 2003; 100:3077-3082.
75. Schilling JD, Machkovech HM, He L, Diwan A, Schaffer JE. TLR4 activation under lipotoxic conditions leads to synergistic macrophage cell death through a TRIF-dependent pathway. J Immunol 2013; 190:1285-1296.
76. Wen H, Gris D, Lei Y etal. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol 2011; 12:408-415.
77. Cascio G, Schiera G, Di Liegro I. Dietary fatty acids in metabolic syndrome, diabetes and cardiovascular diseases. Curr Diabetes Rev 2012; 8:2-17.
78. Herber DL, Cao W, Nefedova Y etal. Lipid accumulation and dendritic cell dysfunction in cancer. Nat Med 2010; 16:880-886.
79. McGill HC, McMahan CA, Herderick EE etal. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation 2002; 105:2712-2718.
80. Tsiantoulas D, Diehl CJ, Witztum JL, Binder CJ. B cells and humoral immunity in atherosclerosis. Circ Res 2014; 114:1743-1756.
81. Mohanta SK, Yin C, Peng L etal. Artery tertiary lymphoid organs contribute to innate and adaptive immune responses in advanced mouse atherosclerosis. Circ Res 2014; 114:1772-1787.
82. Kyaw T, Tipping P, Bobik A, Toh B-H. Protective role of natural IgM-producing B1a cells in atherosclerosis. Trends Cardiovasc Med 2012; 22:48-53.
83. Ait-Oufella H, Herbin O, Bouaziz JD etal. B cell depletion reduces the development of atherosclerosis in mice. J Exp Med 2010; 207:1579-1587.
84. Karlsson EA, Beck MA. The burden of obesity on infectious disease. Exp Biol Med 2010; 235:1412-1424.
85. Anaya DA, Dellinger EP. The obese surgical patient: a susceptible host for infection. Surg Infect (Larchmt) 2006; 7:473-480.
86. Choban PS, Flancbaum L. The impact of obesity on surgical outcomes: a review. J Am Coll Surg 1997; 185:593-603.
87. Weber DJ, Rutala WA, Samsa GP, Santimaw JE, Lemon SM. Obesity as a predictor of poor antibody response to hepatitis b plasma vaccine. JAMA 1985; 254:3187-3189.
88. Milner JJ, Sheridan PA, Karlsson EA, Schultz-Cherry S, Shi Q, Beck MA. Diet-induced obese mice exhibit altered heterologous immunity during a secondary 2009 pandemic H1N1 infection. J Immunol 2013; 191:2474-2485.
89. Sheridan PA, Paich HA, Handy J etal. Obesity is associated with impaired immune response to influenza vaccination in humans. Int J Obes (Lond) 2012; 36:1072-1077.
90. Wallace FA, Miles EA, Evans C, Stock TE, Yaqoob P, Calder PC. Dietary fatty acids influence the production of Th1- but not Th2-type cytokines. J Leukoc Biol 2001; 69:449-457.
91. Davidson MH, Stein EA, Bays HE etal. Efficacy and tolerability of adding prescription omega-3 fatty acids 4g/d to Simvastatin 40mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study. Clin Ther 2007; 29:1354-1367.
92. Kim J, Li Y, Watkins BA. Fat to treat fat: emerging relationship between dietary PUFA, endocannabinoids, and obesity. Prostaglandins Other Lipid Mediat 2013; 104-105:32-41.
93. Kalupahana NS, Claycombe KJ, Moustaid-Moussa N. (n-3) Fatty acids alleviate adipose tissue inflammation and insulin resistance: mechanistic insights. Adv Nutr 2011; 2:304-316.
94. Teague H, Fhaner CJ, Harris M, Duriancik DM, Reid GE, Shaikh SR. n-3 PUFAs enhance the frequency of murine B-cell subsets and restore the impairment of antibody production to a T-independent antigen in obesity. J Lipid Res 2013; 54:3130-3138.
95. Teague H, Harris M, Fenton J, Lallemand P, Shewchuk B, Shaikh SR. Eicosapentaenoic and docosahexaenoic acid ethyl esters differentially enhance B-cell activity in murine obesity. J Lipid Res 2014; 55:1420-1433.
96. Gurzell EA, Teague H, Harris M, Clinthorne J, Shaikh SR, Fenton JI. DHA-enriched fish oil targets B cell lipid microdomains and enhances ex vivo and in vivo B cell function. J Leukoc Biol 2013; 93:463-470.
97. Rockett BD, Teague H, Harris M etal. Fish oil increases raft size and membrane order of B cells accompanied by differential effects on function. J Lipid Res 2012; 53:674-685.
98. Tomasdottir V, Thorleifsdottir S, Vikingsson A, Hardardottir I, Freysdottir J. Dietary omega-3 fatty acids enhance the B1 but not the B2 cell immune response in mice with antigen-induced peritonitis. J Nutr Biochem 2014; 25:111-117.
99. Bannenberg G, Serhan CN. Specialized pro-resolving lipid mediators in the inflammatory response: an update. Biochim Biophys Acta 2010; 1801:1260-1273.
100. Spite M, Clària J, Serhan Charles N. Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases. Cell Metab 2014; 19:21-36.
101. Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature 2014; 510:92-101.
102. Clària J, Dalli J, Yacoubian S, Gao F, Serhan CN. Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat. J Immunol 2012; 189:2597-2605.
103. González-Périz A, Horrillo R, Ferré N etal. Obesity-induced insulin resistance and hepatic steatosis are alleviated by ω-3 fatty acids: a role for resolvins and protectins. FASEB J 2009; 23:1946-1957.
104. Neuhofer A, Zeyda M, Mascher D etal. Impaired local production of proresolving lipid mediators in obesity and 17-HDHA as a potential treatment for obesity-associated inflammation. Diabetes 2013; 62:1945-1956.
105. Morita M, Kuba K, Ichikawa A etal. The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza. Cell 2013; 153:112-125.
106. Ramon S, Gao F, Serhan CN, Phipps RP. Specialized proresolving mediators enhance human B cell differentiation to antibody-secreting cells. J Immunol 2012; 189:1036-1042.
107. Ramon S, Bancos S, Serhan CN, Phipps RP. Lipoxin A4 modulates adaptive immunity by decreasing memory B-cell responses via an ALX/FPR2-dependent mechanism. Eur J Immunol 2014; 44:357-369.